Menu

Bioethicist and Law Professor Dies

John Robertson was known for his contributions to reproductive medicine ethics and for solidifying the scholarly connection between biomedicine and law.

Jul 6, 2017
Kerry Grens

CHRISTINA MURREYJohn Robertson, a bioethicist at the University of Texas School of Law, passed away yesterday (July 5) at age 74. His work focused on reproductive technologies, and he served as chair of the ethics committee of the American Society for Reproductive Medicine.

I. Glenn Cohen, a Harvard Law professor, writes in a memorial that Robertson helped to put law and bioethics “on to the law school map, and with a few others . . . gave it legitimacy as a real and important area of focus within law schools.”

“John was one of the earliest law professors to consider medicine from an ethical and policy perspective,” Rebecca Dresser, a bioethicist and law professor at Washington University in St. Louis, said in a 2010 press release. That year, Robertson was honored with a lifetime achievement award by the American Society for Law, Medicine, & Ethics. “He showed the rest of us how it could be done, and done well.”

Robertson earned his undergraduate degree at Dartmouth College and later studied law at Harvard Law School. After nearly a decade on the faculty at the University of Wisconsin, Robertson moved to the University of Texas School of Law in 1980 and remained there until his death.

He authored several books, notably, 1994’s Children of Choice: Freedom and the New Reproductive Technologies, in which he examined interventions such as in vitro fertilization, genetic screening, and the “morning after pill.” A review of the book in the New England Journal of Medicine called it “indispensible” for anyone involved in making reproductive decisions.

“He was a man of many parts, and an uncommonly modest and warm guy,” fellow UT Law Professor Willy Forbath tells the Austin American-Stateman. “There are not many people at the law school who had such ranging friendships all across the campus.”

July 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.